CN102271502A - 增加内源性缩醛磷脂水平的方法 - Google Patents

增加内源性缩醛磷脂水平的方法 Download PDF

Info

Publication number
CN102271502A
CN102271502A CN2009801536386A CN200980153638A CN102271502A CN 102271502 A CN102271502 A CN 102271502A CN 2009801536386 A CN2009801536386 A CN 2009801536386A CN 200980153638 A CN200980153638 A CN 200980153638A CN 102271502 A CN102271502 A CN 102271502A
Authority
CN
China
Prior art keywords
animal
lcpufa
amount
administered
diet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801536386A
Other languages
English (en)
Chinese (zh)
Inventor
W·R·古费
F·德塔亚
J-B·贝泽尔盖斯
F·迪欧尼斯
C·克鲁兹-赫尔南德斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN102271502A publication Critical patent/CN102271502A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN2009801536386A 2009-01-02 2009-12-30 增加内源性缩醛磷脂水平的方法 Pending CN102271502A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20417009P 2009-01-02 2009-01-02
US61/204,170 2009-01-02
PCT/US2009/006749 WO2010077358A1 (en) 2009-01-02 2009-12-30 Methods for increasing endogenous plasmalogen levels

Publications (1)

Publication Number Publication Date
CN102271502A true CN102271502A (zh) 2011-12-07

Family

ID=42310073

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801536386A Pending CN102271502A (zh) 2009-01-02 2009-12-30 增加内源性缩醛磷脂水平的方法

Country Status (10)

Country Link
US (1) US20110275600A1 (enExample)
EP (1) EP2373161A4 (enExample)
JP (1) JP2012514597A (enExample)
CN (1) CN102271502A (enExample)
AU (1) AU2009333809A1 (enExample)
CA (1) CA2747582A1 (enExample)
MX (1) MX2011007188A (enExample)
RU (1) RU2011132386A (enExample)
WO (1) WO2010077358A1 (enExample)
ZA (1) ZA201105665B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102413822A (zh) * 2009-03-04 2012-04-11 雀巢产品技术援助有限公司 提高哺乳动物中内源性缩醛磷脂水平的方法
CN103314291B (zh) * 2010-12-28 2016-05-11 藤野脑研究株式会社 通过血液样品判定痴呆症用的检验方法
JP5997887B2 (ja) * 2011-09-05 2016-09-28 学校法人帝京大学 経口投与剤
JP5934483B2 (ja) * 2011-09-05 2016-06-15 学校法人帝京大学 リン脂質結合型ｄｈａ増加剤
JP7704407B2 (ja) * 2021-08-04 2025-07-08 株式会社 レオロジー機能食品研究所 がん治療用組成物
JP2023108631A (ja) * 2022-01-26 2023-08-07 大道 藤本 ドッグフード

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124916A1 (en) * 2007-04-13 2008-10-23 Phenomenome Discoveries Inc. Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US8052992B2 (en) * 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US20080033027A1 (en) * 2005-03-21 2008-02-07 Vicus Therapeutics Spe 1, Llc Drug combination pharmaceutical compositions and methods for using them
US20080044487A1 (en) * 2006-05-05 2008-02-21 Natural Asa Anti-inflammatory properties of marine lipid compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124916A1 (en) * 2007-04-13 2008-10-23 Phenomenome Discoveries Inc. Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MANUELA MARTINEZ ET AL.: "Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized perosisomal disorders", 《AM. J. CLIN. NUTR.》 *
MANUELA MARTINEZ: "Restoring the DHA levels in Brains of Zellweger Patients", 《JOURNAL OF MOLECUOLAR NEUROSCIENCE》 *

Also Published As

Publication number Publication date
ZA201105665B (en) 2013-01-30
US20110275600A1 (en) 2011-11-10
AU2009333809A1 (en) 2011-07-14
EP2373161A1 (en) 2011-10-12
JP2012514597A (ja) 2012-06-28
EP2373161A4 (en) 2012-05-30
WO2010077358A1 (en) 2010-07-08
CA2747582A1 (en) 2010-07-08
RU2011132386A (ru) 2013-02-10
MX2011007188A (es) 2011-09-01

Similar Documents

Publication Publication Date Title
JP5931337B2 (ja) 認知機能を高める組成物及び方法
EP1296670B1 (en) Therapeutic combinations of fatty acids
AU2416299A (en) Fat blend
AU2001274276A1 (en) Therapeutic combinations of fatty acids
CN102271502A (zh) 增加内源性缩醛磷脂水平的方法
JP2014515011A (ja) 加齢に伴う疾病を改善するのに有用な組成物及び方法
CN106793800A (zh) 用于增强运动性或活动性或者治疗体弱的组合物和方法
JPH04501114A (ja) トリグリセリド，該トリグリセリドを含んでなる栄養組成物、および栄養物用の栄養組成物の使用
RU2413427C2 (ru) Способы и композиция для улучшения когнитивной функции
WO2014022816A2 (en) Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
CN106998748A (zh) 用于治疗癫痫的包含中链甘油三酯的组合物和方法
US20040132819A1 (en) Appetite control method
EP1893039B1 (en) Method for treatment and prevention of respiratory insufficiency
JP2014505679A (ja) 変形性関節症の予防及び治療のための方法及び組成物
CN107072277A (zh) 用于改善行为的脂质组合物
JP2018177734A (ja) 脂質吸収促進剤
HK1050486B (en) Therapeutic combinations of fatty acids

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20111207